fla 797 has been researched along with Basal Ganglia Diseases in 1 studies
*Basal Ganglia Diseases: Diseases of the BASAL GANGLIA including the PUTAMEN; GLOBUS PALLIDUS; claustrum; AMYGDALA; and CAUDATE NUCLEUS. DYSKINESIAS (most notably involuntary movements and alterations of the rate of movement) represent the primary clinical manifestations of these disorders. Common etiologies include CEREBROVASCULAR DISORDERS; NEURODEGENERATIVE DISEASES; and CRANIOCEREBRAL TRAUMA. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lundström, J; Nilsson, LB; Ogren, SO | 1 |
1 other study(ies) available for fla 797 and Basal Ganglia Diseases
| Article | Year |
|---|---|
Concentrations of remoxipride and its phenolic metabolites in rat brain and plasma. Relationship to extrapyramidal side effects and atypical antipsychotic profile.
Topics: Animals; Basal Ganglia Diseases; Brain; Catalepsy; Chromatography, High Pressure Liquid; Circadian Rhythm; Dose-Response Relationship, Drug; Haloperidol; Injections, Intraperitoneal; Injections, Intravenous; Injections, Subcutaneous; Male; Rats; Rats, Sprague-Dawley; Remoxipride; Salicylamides; Spectrophotometry, Ultraviolet | 1993 |